Facebook Intervention for Relapse

Phase-Based Progress Estimates
Mayo Clinic Rochester, Rochester, MN
Relapse+1 More
Wiidookaage'win Facebook Group - Behavioral
What conditions do you have?

Study Summary

The purpose of this study is to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use.

Eligible Conditions

  • Relapse
  • Opioids Use

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Relapse

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 30 days

30 days
MOUD retention as assessed by a Yes/No answer on 30-day follow-up survey
Number of days since opioid abstinence as assessed by the Timeline Follow-back Interview
The acceptability of using Facebook as an opioid intervention platform as assessed by the 13-item Social Media Usability Scale (Lund et al., 2001) and post, reaction, and comment data extracted from Facebook (https://pypi.org/project/facebook-scraper/)
The development of a culturally relevant Facebook intervention prototype to support recovery from opioid use
The feasibility of using Facebook as an opioid intervention platform as assessed by the number of participants enrolled out of those screened and the number of participants who complete the follow-up assessments

Trial Safety

Safety Progress

1 of 3

Other trials for Relapse

Trial Design

1 Treatment Group

Facebook Intervention
1 of 1
Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Facebook Intervention · No Placebo Group · N/A

Facebook Intervention
Experimental Group · 1 Intervention: Wiidookaage'win Facebook Group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days

Trial Background

Christi Patten, Principal Investigator
Principal Investigator
Mayo Clinic
Closest Location: Mayo Clinic Rochester · Rochester, MN
Photo of Mayo Clinic Rochester  1Photo of Mayo Clinic Rochester  2Photo of Mayo Clinic Rochester  3
2005First Recorded Clinical Trial
0 TrialsResearching Relapse
156 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Female Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.